APA (7th ed.) Citation

Burnham, S. C., Raghavan, N., Wilson, W., Baker, D., Ropacki, M. T., Novak, G., . . . Group, A. R. (2015). Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study. Journal of Alzheimer's Disease, 46(4), 1079. https://doi.org/10.3233/JAD-143015

Chicago Style (17th ed.) Citation

Burnham, Samantha C., et al. "Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study." Journal of Alzheimer's Disease 46, no. 4 (2015): 1079. https://doi.org/10.3233/JAD-143015.

MLA (9th ed.) Citation

Burnham, Samantha C., et al. "Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study." Journal of Alzheimer's Disease, vol. 46, no. 4, 2015, p. 1079, https://doi.org/10.3233/JAD-143015.